z-logo
open-access-imgOpen Access
Toward aNOTCH1/FBXW7/RAS/PTEN–Based Oncogenetic Risk Classification of Adult T-Cell Acute Lymphoblastic Leukemia: A Group for Research in Adult Acute Lymphoblastic Leukemia Study
Author(s) -
Amélie Trinquand,
Aline Schmidt,
Raouf Ben Abdelali,
Jérôme Lambert,
Kheïra Beldjord,
Étienne Lengliné,
Noémie de Gunzburg,
Dominique PayetBornet,
Ludovic Lhermitte,
Hossein Mossafa,
Véronique Lhéritier,
Jonathan Bond,
Françoise Huguet,
Agnès Buzyn,
T. Leguay,
JeanYves Cahn,
Xavier Thomas,
Yves Chalandon,
André Delannoy,
Caroline Bonmati,
Sébastien Maury,
Bertrand Nadel,
Elizabeth Macintyre,
Norbert Ifrah,
Hervé Dombret,
Vahid Asnafi
Publication year - 2013
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2012.48.5292
Subject(s) - pten , medicine , hazard ratio , oncology , leukemia , lymphoblastic leukemia , cancer research , genetics , biology , confidence interval , pi3k/akt/mtor pathway , apoptosis
The Group for Research in Adult Acute Lymphoblastic Leukemia (GRAALL) recently reported a significantly better outcome in T-cell acute lymphoblastic leukemia (T-ALL) harboring NOTCH1 and/or FBXW7 (N/F) mutations compared with unmutated T-ALL. Despite this, one third of patients with N/F-mutated T-ALL experienced relapse.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom